Daewoong Pharmaceutical is hosting a web symposium to highlight the shift towards continuous glucose monitoring (CGM) technology, aiming to modernise diabetes care with insights from international clinical experiences and new treatment trends for Korean clinicians. Daewoong Pharmaceutical said it will…
Research from Denmark suggests initiating statin therapy soon after a type 2 diabetes diagnosis could lower the risk of developing dementia later in life, highlighting the potential added benefits of early vascular protection. New Danish research suggests that starting statin…
Unripe green bananas, rich in resistant starch, could provide health advantages such as better blood sugar control and digestive health, challenging perceptions that only ripe bananas are nutritious. Green bananas are not just safe to eat before they turn yellow;…
Beta Bionics secures FDA clearance for its first insulin patch pump, Mint, promising an earlier market launch and increasing competition in the industry dominated by Insulet. Beta Bionics has won U.S. Food and Drug Administration clearance for Mint, its first…
Delaware has enacted House Bill 305, broadening access to early intervention for diabetes through expanded programmes and technological support, aiming to improve health outcomes and reduce long-term costs. Delaware has moved to broaden access to preventive diabetes care after Governor…
Integrating blood sugar discussions into routine eye care can deepen patient relationships, promote better metabolic health, and foster comprehensive disease management, says optometrist Abigail Hartle. Talking to patients about blood sugar can do more than fill a gap in routine…
Senseonics plans to combine its long-term Eversense 365 glucose monitor with Beta Bionics’ iLet Bionic Pancreas, aiming for a fully automated, carb-counting-free diabetes management system set for commercial launch in late 2026. Senseonics is planning to pair its Eversense 365…
A 12-week Johns Hopkins Medicine study reveals that limiting eating to a 10-hour window results in slight weight loss among adults with obesity and prediabetes, adding to mixed evidence on meal timing benefits. A Johns Hopkins Medicine study has found…
At Neighborhood Health Center in Indiana, a pioneering partnership with Gleaners Food Bank is redefining healthcare by integrating food access into medical treatment, improving chronic disease management and reducing hospital visits. At Neighborhood Health Center in Liberty, Indiana, staff are…
Research presented at the European Respiratory Society Congress reveals that the GLP-1 drug semaglutide may lower exacerbation rates in asthma and COPD patients, suggesting benefits beyond blood sugar control. Semaglutide, the GLP-1 drug used to treat type 2 diabetes and…
